ST. LOUIS CHILDRENS HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.1M
- Transactions
- 722
- Companies
- 27
- Average per transaction
- $2,882
Who reported the payments
| Pfizer | $1,157,968 |
| Takeda Pharmaceuticals U.S.A., Inc. | $453,906 |
| Merck | $163,010 |
| Linde Gas & Equipment Inc. | $95,670 |
| EMD Serono, Inc. | $45,450 |
| Berlin Heart Inc | $35,710 |
| Stryker | $31,413 |
| Merit Medical Systems Inc | $29,852 |
| Octapharma USA, Inc. | $15,331 |
| Janssen Research & Development, LLC | $11,329 |
| Abbott | $8,515 |
| Med-el Corporation | $7,950 |
| Masimo Corporation | $6,688 |
| Sarepta Therapeutics, Inc. | $6,615 |
| Aesculap, Inc. | $3,332 |
| Medtronic | $2,500 |
| Oticon Medical, LLC | $1,562 |
| Steris Corporation | $1,000 |
| B. Braun Medical Inc. | $760 |
| Hikma Pharmaceuticals USA | $654 |
| Daiichi Sankyo Inc. | $470 |
| 3M Company | $420 |
| Recordati_rare_diseases_inc. | $380 |
| Cochlear Americas | $172 |
| Olympus America Inc. | $164 |
| American National Red Cross | $129 |
| Regeneron | $100 |